PGAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.14400044992635E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.8187999997279E-07 |
Normal-vs-Stage2 |
6.41419999999338E-05 |
Normal-vs-Stage3 |
6.85207446338154E-12 |
Normal-vs-Stage4 |
2.37532216118552E-12 |
Stage1-vs-Stage2 |
3.735800E-01 |
Stage1-vs-Stage3 |
1.056960E-03 |
Stage1-vs-Stage4 |
2.019000E-04 |
Stage2-vs-Stage3 |
1.760970E-01 |
Stage2-vs-Stage4 |
1.318230E-01 |
Stage3-vs-Stage4 |
7.163000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.96379953701864E-10 |
Normal-vs-AfricanAmerican |
3.18009996114199E-09 |
Normal-vs-Asian |
2.296200E-02 |
Caucasian-vs-AfricanAmerican |
1.300220E-01 |
Caucasian-vs-Asian |
9.809800E-01 |
AfricanAmerican-vs-Asian |
5.132200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.18809456401459E-11 |
Normal-vs-Female |
5.31489999788803E-08 |
Male-vs-Female |
4.218600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.02409999988862E-07 |
Normal-vs-Age(41-60Yrs) |
8.63819999974424E-08 |
Normal-vs-Age(61-80Yrs) |
2.49010034814034E-10 |
Normal-vs-Age(81-100Yrs) |
1.71611999999488E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.319770E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.693000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.962200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.807800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.573400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.605800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.453900E-02 |
Normal-vs-Grade 2 |
2.46389999999375E-05 |
Normal-vs-Grade 3 |
1.66344715779587E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
7.839000E-01 |
Grade 1-vs-Grade 3 |
5.687700E-02 |
Grade 1-vs-Grade 4 |
4.233600E-04 |
Grade 2-vs-Grade 3 |
2.009000E-04 |
Grade 2-vs-Grade 4 |
9.09869957155252E-10 |
Grade 3-vs-Grade 4 |
1.143590E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.826380E-04 |
Normal-vs-ccB subtype |
1.03680397600669E-11 |
ccA subtype-vs-ccB subtype |
2.39909999999455E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.6080000381512E-09 |
Normal-vs-N1 |
1.52190000046737E-07 |
N0-vs-N1 |
5.136400E-02 |
|
|